 |
Tompkins, Bryon A; Difede, Darcy L.; Khan, Aisha; Landin, Ana Marie; Shulman, Yvonne Hernandez; Pujol, Marietsi V.; Heldman, Alan W.; Miki, Roberto; Goldschmidt-Clermont, Pascal J.; Goldstein, Bradley J.; Mushtaq, Muzammil; Levis-Dussault, Silvina; Burns, John Jay; Lowry, Maureen; Natsumeda, Makoto; Delgado, Cindy; Salzman, Russell; Vidrocasiano, Myra; Da Fonseca, Moisaniel; Golpanian, Samuel; Premer, Courtney; Medina, Audrey; Valasaki, Crystal; Florea, Victoria; Anderson, Erica; El Khorazati, Jill; Mendizabal, Adam; Green, Jeff; Oliva, Anthony A.; Hare, Joshua M. (November 2017). "Allogeneic mesenchymal stem cells reduce senile weakness: The second phase of a randomized, double-blind, placebo-controlled clinical trial of <a href=https://cityconnectioncafe.com/?p=145>https://cityconnectioncafe.com/?p=145</a>." |
